Aim-Since most forms ofKaposi sarcoma are much more common in men than in women, the aim of this study was to examine serum (_ Clin Pathol 1995;48:513-518) 
The epidemic form of Kaposi sarcoma, which is associated with HIV infection, is also exceptionally common among male patients,"
and homosexual and bisexual men are 10 times more at risk.' Certain factors favour the development ofKaposi lesions. Various cytokines, particularly IL6, can act as autocrine/paracrine growth factor for AIDS associated Kaposi sarcoma.45 Glucocorticoids also favour the formation of Kaposi lesions. 6 There have been reports7 of Kaposi sarcoma developing during the treatment of HIV patients with corticoids. The incidence of this condition began to increase with the use of immunosuppressive therapy for transplant recipients.8 Experimental studies also show that lesions resembling those of Kaposi sarcoma develop in male transgenic mice, but not in females. 9 There is now general agreement that the steroid hormone profile of patients infected with HIV changes during the course of the viral infection."" '4 The serum concentrations of cortisol are normal or slightly high at all stages of HIV infection." ' '14 By contrast, androgen levels appear to be closely correlated with the stage of HIV infection.'4 Asymptomatic HIV positive men (stages II and III) in general have high serum concentrations of androgens (dehydroepiandrosterone (DHEA), androstenedione, testosterone), whereas those with AIDS have subnormal androgen concentrations. There is also evidence for a relationship between CD4 count and serum DHEA or DHEA sulphate values in HIV infected men at risk of progression to AIDS. '5 These changes in hormone concentrations, particularly of the androgen profile, during the course of HIV infection might result in significant alterations in immune competence, especially cytokine profiles and T cell activity and function.'617 Androgens, such as DHEA and DHEA sulphate, enhance in vivo the capacity of activated helper T cell to produce IL-2,18 even in the presence of glucocorticoids, '8 which inhibit IL-2 production. 18 The production of IL-2 is decreased in subjects with progression of HIV-1 infection. ' The CD4 cell count indicated that patients with >500 CD4 lymphocytes had had no opportunistic infections or treatment; in the 500-200 CD4 range, KS + patients had no opportunistic infections but the KS -patients included one who had had tuberculosis, one with ocular toxoplasmosis, and one with gastric lymphoma. KS + patients with <200 CD4 lymphocytes included one with toxoplasmosis, one with cytomegalovirus (CMV) retinitis, and two with previous Kaposi sarcomas; KS -patients with <200 CD4 lymphocytes included one with toxoplasmosis, one with multifocal leucoencephalitis, and one with a lymphoma. Antiviral therapy was given as follows: in the 500-200 CD4 cell group, one KS + patient had taken zidovudine, and two had taken imuthiol; two KS -patients had taken zidovudine and one had taken imuthiol; in the <200 CD4 cell group, six KS+ patients had been given antiviral treatment (four zidovudine, two zidovudine followed by DDI), two had taken interferon oc2b four years earlier; seven KSpatients had had zidovudine and two had had imuthiol. Five KS + and six KS -patients had primary prophylactic pneumocystosis. Patients were not treated with ketoconazol, glucocorticoids, or interferon at the time the western blots were taken.
The control group consisted of 35 HIV negative male blood donors aged 18-50 years.
BLOOD SAMPLES Blood samples were collected between 0800 and 1000 and allowed to coagulate before separation of serum by centrifugation (3000 rpm/ 10 minutes at 4°C). Serum samples were stored at -20°C until assayed.
STEROID EXTRACTION AND CHROMATOGRAPHIC FRACTIONATION
(1) Serum samples (1 ml) were extracted for 30 min with 5 ml of organic solvent (ethyl acetate/cyclohexane, 1/1) and the aqueous phase was removed by freezing (-20°C). The organic phase was evaporated to dryness, taken up in 1 ml ofsolvent system I (benzene/ethanol, 95/5) and placed on a Sephadex LH20 microcolumn (0 5 x 6 cm). Progesterone and androstenedione were first eluted with 2-6 ml of solvent I. Oestrone was then eluted with 3 5 ml ofsolvent I followed by 1 0 ml ofsolvent II (benzene/ethanol, 90/ 10). Finally, oestradiol and cortisol were eluted with 6 
